However, the efficacy of these interventions varies due to individual genetic backgrounds, dietary habits, and baseline microbiome differences [251, 259,260,261,262]
What happens next in this space Retatrutides Phase 3 program (called TRIUMPH) includes multiple ongoing trials across different patient populations, with additional results expected throughout 2026
In addition, two studies have indicated that purine metabolism is upregulated in epileptic patients (134, 139), with increased serum uric acid levels (134)
These ingredients work through minor metabolic tweaks, not through the hormone-receptor interaction that drives clinical weight loss